- Home
- ROL vs DXCM Comparison
ROL vs DXCM Comparison
Compare ROL & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROL
- DXCM
- Stock Information
- Founded
- ROL 1948
- DXCM 1999
- Country
- ROL United States
- DXCM United States
- Employees
- ROL N/A
- DXCM N/A
- Industry
- ROL Diversified Commercial Services
- DXCM Medical/Dental Instruments
- Sector
- ROL Finance
- DXCM Health Care
- Exchange
- ROL Nasdaq
- DXCM Nasdaq
- Market Cap
- ROL 27.6B
- DXCM 34.1B
- IPO Year
- ROL N/A
- DXCM 2005
- Fundamental
- Price
- ROL $56.44
- DXCM $82.93
- Analyst Decision
- ROL Buy
- DXCM Strong Buy
- Analyst Count
- ROL 8
- DXCM 20
- Target Price
- ROL $58.75
- DXCM $98.50
- AVG Volume (30 Days)
- ROL 1.7M
- DXCM 3.7M
- Earning Date
- ROL 07-23-2025
- DXCM 07-30-2025
- Dividend Yield
- ROL 1.17%
- DXCM N/A
- EPS Growth
- ROL 9.41
- DXCM N/A
- EPS
- ROL 0.99
- DXCM 1.33
- Revenue
- ROL $3,462,863,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- ROL $11.84
- DXCM $16.74
- Revenue Next Year
- ROL $8.58
- DXCM $15.29
- P/E Ratio
- ROL $57.28
- DXCM $62.25
- Revenue Growth
- ROL 9.46
- DXCM 9.11
- 52 Week Low
- ROL $45.34
- DXCM $57.52
- 52 Week High
- ROL $58.65
- DXCM $117.19
- Technical
- Relative Strength Index (RSI)
- ROL 48.99
- DXCM 48.21
- Support Level
- ROL $54.97
- DXCM $82.75
- Resistance Level
- ROL $57.25
- DXCM $87.49
- Average True Range (ATR)
- ROL 0.97
- DXCM 2.64
- MACD
- ROL -0.10
- DXCM -0.16
- Stochastic Oscillator
- ROL 55.89
- DXCM 48.72
About ROL Rollins Inc.
Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.